NCT06032611

Brief Summary

The goal of this clinical trial is to compare conventional clinical data collected as part of usual practice with data collected by the two digital tools to help diagnose major and minor neurocognitive disorders in elderly people consulting a memory center for cognitive complaints. The main question\[s\] it aims to answer are:

  • Is it possible to create a classification between the different intensities of cognitive impairment?
  • Is it possible to create a diagnostic tool consistent with the reference diagnosis? Participants will be asked to complete a series of cognitive and fine motor tasks, and will be given questionnaires on their lifestyle and medical history. They will be asked to wear a connected watch for 1 week. There is no comparison group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2024

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

1 year

First QC Date

September 1, 2023

Last Update Submit

September 8, 2023

Conditions

Keywords

tabletsmartwatchdiagnosis

Outcome Measures

Primary Outcomes (1)

  • Sensitivity, specificity, accuracy

    Sensitivity, specificity, accuracy of the classification proposed by the algorithm in relation to the reference diagnosis.

    through study completion, an average of 1 year

Study Arms (1)

Intervention

EXPERIMENTAL

Participants will complete a number of cognitive and fine motor tests on a touch-sensitive tablet. They will also be asked to complete a questionnaire on their habits and medical history. They will also be asked to wear a smartwatch for 7 days.

Diagnostic Test: COGNUM_ALZVR

Interventions

COGNUM_ALZVRDIAGNOSTIC_TEST

Participants will complete a battery of tests/quizzes: * cognitive tests * medical questionnaire * lifestyle/fragility questionnaire * digital clock test * fine motor skills tests They will also wear a connected watch for 7 days.

Intervention

Eligibility Criteria

Age60 Years - 110 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elderly people consulting the memory center ;
  • people with one of three documented cognitive diagnoses:
  • major neurocognitive impairment due to Alzheimer's disease according to DSM-5 criteria,
  • mild neurocognitive impairment
  • no documented cognitive dysfunction after assessment at the memory center,
  • willingness to participate in the study and sign the consent form.

You may not qualify if:

  • persons with an illness affecting the hand (orthopedic, neurological, Parkinson's disease) that prevents them from using a touch-sensitive tablet;
  • persons with other illnesses that may be responsible for loss of cognitive function (cerebrovascular disease, other neurological illnesses, psychiatric illnesses);
  • persons benefiting from legal protection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Privé Gériatrique Les Magnolias

Ballainvilliers, Essonne, 91160, France

RECRUITING

Hôpital Charles Foix

Ivry-sur-Seine, Val De Marne, 94200, France

RECRUITING

MeSH Terms

Conditions

Neurocognitive DisordersDisease

Condition Hierarchy (Ancestors)

Mental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Joël Belmin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2023

First Posted

September 13, 2023

Study Start

April 17, 2023

Primary Completion

April 17, 2024

Study Completion

April 17, 2024

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Personal data is password-protected and not shared; only investigators have access to this data. Study data that is shared is pseudonymized by a unique alphanumeric code generated by the application.

Locations